⌕
Guardant Health · GH · Nasdaq
Tenet 48 · Mixed
Compare
$143.28−0.52%At closeTenet 48 · Mixed
$143.28−0.75 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Guardant Health (GH) Stock

Guardant Health (GH) closed at $143.28 on Nov 17, 2026; its Tenet Score is 48 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

32 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$143.28
Nov 17, 2026
Market cap
$19.5B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
74.55 – 191.05
low → high · as of close, Nov 16, 2026
Tenet Score
48/100
Mixed · 340 Healthcare peers

Industry: Health Services

Guardant Health Inc scores 48/100. Mixed. Quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 48 is built from 3 of 4 pillars, from 45% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=340
48/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
—
Quality
38
Health
57
Growth
49

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Value omitted — no data yet.
Value—QualityDHealthCGrowthDMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
—
Not meaningful: shareholders' equity is zero or negative.
P/S
15.2×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
—
Not meaningful: shareholders' equity is zero or negative.
Operating margin
−44.5%
fiscal 2025, before interest and tax
Net margin
−37.9%
TTM through Sep 30, 2026
Current ratio
3.60
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for ad…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 184 US ETFs · top wrappers by weightSee all ETFs holding GH →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Guardant Health in?

Guardant Health is in the Healthcare sector and the Health Services industry.

What is Guardant Health's Tenet Score?

Guardant Health's Tenet Score is 48 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.